ACPE Accredited** Pharm So Hard Ambulatory Care Podcast Episodes

0% Complete

0/0 Steps

Women’s Health

Oral Contraception Overview

1 Quiz
- Assessment Questions: Women’s Health Series – Oral Contraception
Empowering Access: The Role of Pharmacists in Prescribing Hormonal Contraception

1 Quiz
- Assessment Questions: The Role of Pharmacists in Prescribing Hormonal Contraception
Emergency Contraception: What You Need to Know

1 Quiz
- Assessment Questions: Emergency Contraception: What You Need to Know
GLP-1 Agonists

GLP-1 Agonists Unveiled Series: Introduction to GLP-1 Agonists in Obesity

1 Quiz
- Assessment Questions: GLP-1 Agonists Unveiled Series: Introduction to GLP-1 Agonists in Obesity
Diving Deep: The Literature on GLP-1 Agonists

1 Quiz
- Assessment Questions: Diving Deep: The Literature on GLP-1 Agonists
The Great Debate: Unpacking the Controversy of GLP-1 Agonists

1 Quiz
- Assessment Questions: The Great Debate: Unpacking the Controversy of GLP-1 Agonists

Participants 407

Allison Clemens
April
ababaabhay
achoi2392
adhoward1

Quiz 4 of 6

← Previous Next→

Assessment Questions: GLP-1 Agonists Unveiled Series: Introduction to GLP-1 Agonists in Obesity

ACPE Accredited** Pharm So Hard Ambulatory Care Podcast Episodes GLP-1 Agonists Unveiled Series: Introduction to GLP-1 Agonists in Obesity Assessment Questions: GLP-1 Agonists Unveiled Series: Introduction to GLP-1 Agonists in Obesity

Time limit: 0

Quiz Summary

0 of 10 Questions completed

Questions:

Information

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 10 Questions answered correctly

Your time:

Time has elapsed

You have reached 0 of 0 point(s), (0)

Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)

Categories

Not categorized 0%

Current
Review
Answered
Correct
Incorrect

Question 1 of 10

1. Question
What is the primary reason GLP-1 receptor agonists are considered superior to other antihyperglycemic drugs?
- A) They increase glucagon secretion
- B) They improve glycemic control, support weight loss, and provide cardioprotective benefits
- C) They work faster than insulin
- D) They have no side effects
Correct

Incorrect
Question 2 of 10

2. Question
Which GLP-1 receptor agonist was the first to be approved by the FDA?
- A) Semaglutide (Ozempic)
- B) Liraglutide (Victoza)
- C) Exenatide (Byetta)
- D) Dulaglutide (Trulicity)
Correct

Incorrect
Question 3 of 10

3. Question
Which of the following best describes how GLP-1 receptor agonists assist in weight loss?
- A) They directly burn fat by increasing metabolism
- B) They suppress appetite and slow gastric emptying
- C) They cause rapid dehydration
- D) They enhance carbohydrate metabolism
Correct

Incorrect
Question 4 of 10

4. Question
Why do GLP-1 receptor agonists have a lower risk of hypoglycemia compared to insulin?
- A) They suppress all glucose production
- B) Their insulin secretion effects are glucose-dependent
- C) They completely replace pancreatic beta cells
- D) They eliminate the need for dietary carbohydrates
Correct

Incorrect
Question 5 of 10

5. Question
Which of the following conditions is a contraindication for GLP-1 receptor agonist use?
- A) Medullary thyroid carcinoma
- B) Hypertension
- C) Type 2 diabetes
- D) Non-alcoholic fatty liver disease (NAFLD)
Correct

Incorrect
Question 6 of 10

6. Question
Which GLP-1 receptor agonist has been studied for its effects on cardiovascular disease?
- A) Exenatide
- B) Liraglutide
- C) Lixisenatide
- D) Albiglutide
Correct

Incorrect
Question 7 of 10

7. Question
Which of the following is a common side effect of GLP-1 receptor agonists?
- A) Hyperglycemia
- B) Hypertension
- C) Nausea
- D) Bradycardia
Correct

Incorrect
Question 8 of 10

8. Question
Which of the following GLP-1 receptor agonists is a dual GLP-1 and GIP receptor agonist?
- A) Exenatide
- B) Liraglutide
- C) Tirzepatide
- D) Semaglutide
Correct

Incorrect
Question 9 of 10

9. Question
What is a major barrier to patient access for GLP-1 receptor agonists discussed in the episode?
- A) Lack of FDA approval
- B) High cost and insurance restrictions
- C) Frequent hospitalizations
- D) Risk of severe hypoglycemia
Correct

Incorrect
Question 10 of 10

10. Question
Which GLP-1 receptor agonist is FDA-approved for chronic weight management?
- A) Liraglutide (Saxenda)
- B) Exenatide (Byetta)
- C) Dulaglutide (Trulicity)
- D) Lixisenatide (Adlyxin)
Correct

Incorrect

ACPE Accredited** Pharm So Hard Ambulatory Care Podcast Episodes

Women’s Health

Participants 407

Assessment Questions: GLP-1 Agonists Unveiled Series: Introduction to GLP-1 Agonists in Obesity

Quiz Summary

Information

Results

Results

Categories

1. Question

2. Question

3. Question

4. Question

5. Question

6. Question

7. Question

8. Question

9. Question

10. Question